Skip to content
Sign in
Artwork for BioVenture VoiCes with Chris Garabedian
BioVenture VoiCes with Chris Garabedian · Dec 29, 2025 · 1 hr 2 min

Episode 31: Polaris Partners' Amy Schulman

She describes her career beginnings as a lawyer, which led to general counsel and business unit head roles at Pfizer, and then joining the VC world at Polaris Partners (at Bob Langer's urging). She discusses the firm's investment philosophy, the nuances behind how companies choose lead assets, and the cycles biotech has been through over the last ten years. Plus, other roles she currently serves, including being the chair of Alnylam.

0:00-1:02:40
Play in podnod

transcript

No transcript — this publisher did not publish one.

show notes

She describes her career beginnings as a lawyer, which led to general counsel and business unit head roles at Pfizer, and then joining the VC world at Polaris Partners (at Bob Langer's urging). She discusses the firm's investment philosophy, the nuances behind how companies choose lead assets, and the cycles biotech has been through over the last ten years. Plus, other roles she currently serves, including being the chair of Alnylam.

more episodes

All episodes